Clinical Outcomes After Bilateral Implantation of a Diffractive Trifocal Intraocular Lens: A Worldwide Pooled Analysis of Prospective Clinical Investigations.

Thomas KohnenRuth Lapid-GortzakDandapani RamamurthyHiroko Bissen-MiyajimaAndrew MaxwellTae-Im KimSatish S Modi

Published in: Clinical ophthalmology (Auckland, N.Z.) (2023)

This global pooled analysis showed that TFNT00 provided a continuous range of 0.1 logMAR (~20/25 Snellen) or better vision from distance to 33 cm, with a low incidence of ocular adverse device effects and SSIs.

Keyphrases

risk factors
clinical trial
phase iii